Literature DB >> 14521990

Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease.

J L W Yau1, S Rasmuson, R Andrew, M Graham, J Noble, T Olsson, E Fuchs, R Lathe, J R Seckl.   

Abstract

Neurosteroids such as dehydroepiandrosterone (DHEA), pregnenolone and 17beta-estradiol are synthesized by cytochrome P450s from endogenous cholesterol. We previously reported a new cytochrome P450 enzyme, CYP7B, highly expressed in rat and mouse brain that metabolizes DHEA and related steroids by hydroxylation at the 7alpha position. Such 7-hydroxylation can enhance DHEA bioactivity in vivo. Here we show that the reaction is conserved across mammalian species: in addition to mouse and rat, DHEA hydroxylation activity was present in brain extracts from sheep, marmoset and human. Northern blotting using a human CYP7B complementary deoxyribonucleic acid (cDNA) probe confirmed the presence of CYP7B mRNA in marmoset and human hippocampus; CYP7B mRNA was present in marmoset cerebellum and brainstem, with lower levels in hypothalamus and cortex. In situ hybridization to human brain revealed higher levels of CYP7B mRNA in the hippocampus than in cerebellum, cortex, or other brain regions. We also measured CYP7B expression in Alzheimer's disease (AD). CYP7B mRNA was significantly decreased (approximately 50% decline; P<0.05) in dentate neurons from AD subjects compared with controls. A decline in CYP7B activity may contribute the loss of effects of DHEA with ageing and perhaps to the pathophysiology of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521990     DOI: 10.1016/s0306-4522(03)00438-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

Authors:  Prasant Kumar Jena; Lili Sheng; Jacopo Di Lucente; Lee-Way Jin; Izumi Maezawa; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

2.  Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.

Authors:  Jennifer C Naylor; Christine M Hulette; David C Steffens; Lawrence J Shampine; John F Ervin; Victoria M Payne; Mark W Massing; Jason D Kilts; Jennifer L Strauss; Patrick S Calhoun; Rohana P Calnaido; Daniel G Blazer; Jeffrey A Lieberman; Roger D Madison; Christine E Marx
Journal:  J Clin Endocrinol Metab       Date:  2008-05-13       Impact factor: 5.958

Review 3.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Genetic connections between neurological disorders and cholesterol metabolism.

Authors:  Ingemar Björkhem; Valerio Leoni; Steve Meaney
Journal:  J Lipid Res       Date:  2010-05-13       Impact factor: 5.922

5.  7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system.

Authors:  Masahiro Matsunaga; Kazuyoshi Ukena; Etienne-Emile Baulieu; Kazuyoshi Tsutsui
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

6.  Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations.

Authors:  Afraa Siam; Andrea Brancale; Claire Simons
Journal:  J Mol Model       Date:  2011-05-04       Impact factor: 1.810

7.  Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation.

Authors:  Marjan Shafaati; Amelia Marutle; Hanna Pettersson; Anita Lövgren-Sandblom; Maria Olin; Irina Pikuleva; Bengt Winblad; Agneta Nordberg; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2011-02-19       Impact factor: 5.922

8.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

Review 9.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

10.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.